LINC02883

Across TCGA pan-cancer cohorts, LINC02883 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02883’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC02883 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02883 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

STAD, UCEC, and BRCA are the cancer types where LINC02883 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02883 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	+0.205	<.001	8	view →
UCEC	All	III,IV	+0.551	<.001	6	view →
BRCA	All	All	−0.405	<.001	6	view →
COAD	All	All	+0.251	.001	5	view →
READ	All	All	+0.302	.008	3	view →
PRAD	All	All	+0.089	.049	2	view →
KIRC	Female	IV	−0.151	.008	1	view →
THCA	All	All	+0.091	.048	1	view →
KIRP	All	All	−0.067	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC02883–STAD

Open the STAD breakdown →